New eye treatment effective in laboratory tests

A promising technique for treating human eye disease has proven effective in preclinical studies and may lead to new treatments to prevent blindness

UC Berkeley neuroscientist featured for work on decoding brain activity

Clariant uncaps potential to protect healthcare products

New additions to USP/ISO additive range using biologically pre-evaluated raw materials shown at K2013 boost productivity potential and help achieve the end-goals of design appeal and regulatory compliance

‘Trojan horse’ approach to TBI diagnosis

Existing imaging options can’t see most traumatic brain injuries (TBI) and concussions, so tracers are being used to identify them via PET scans

Renal denervation market will pick up by 2016

Chronic heart failure to boost future growth with 25% share of renal denervation market by 2016, GlobalData forecasts

UNITAID rolls out rapid diagnostic testing for TB

Global health organisation at forefront of efforts to tackle drug-resistant and pediatric TB

FDA to complete phase-out of CFC inhalers

Two products currently remain on the market, but will no longer be available after the end of 2013

Single QMS audit program pilot for medical devices set for January 2014

Flu shot halves risk of heart attack or stroke

In people with history of heart attack, flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent

Chinese regulators considering new clinical trial, adverse event reporting requirements

Unilever's growth tapers in Q3

Unilever's reported revenues fell 6.5% to 12.5 billion euros, but its personal care and laundry sales are still performing well.

Revlon sales down at Q3

Revlon, Inc. posted results for the third quarter ended Sept. 30, 2013. Net sales fell 2.2% to $339.4 million.